Product Images Finasteride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Finasteride NDC 47335-715 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure 1.jpg - finasteride figure 1
The text describes a figure titled "Symptom Score in The Long-Term Efficacy And Safety Study" that shows the mean change from baseline with 1 standard error (SE). The x-axis likely represents time, with baseline, year 1, year 2, year 3, and an additional year labeled as "Yeard". The y-axis represents symptom score. The figure includes data for the drug Finasteride, with scores of 1296, 1101, 961, and 85 at baseline, year 1, year 2/3, and "Yeard", respectively. The figure also includes a legend that appears to indicate a group labeled "PP".*
figure 2.jpg - finasteride figure 2
This is a graph showing the percentage of patients who had surgery for BPH, including TURP over time. The X-axis represents the observation time in months while the Y-axis represents the percentage of patients. There are two groups represented in the graph: the Placebo Group and the Finasteride Group. The graph shows that the number of events (i.e., patients having surgery) in the Finasteride Group is lower than that in the Placebo Group.*
finasteride-figure-3.jpg - finasteride figure 3
The text contains a figure representing the Percent of Patients Developing Acute Urinary Retention over time for two groups - Frasiorde and Placebo, and a graph for Observation Time. The figure displays the number of events and cumulative values for each group at different timepoints. There is also some irrelevant text and non-English characters that can be ignored.*
finasteride-figure-4.jpg - finasteride figure 4
finasteride-figure-5.jpg - finasteride figure 5
The figure (Figure 5) shows the cumulative incidence of a 4-point rise in AUA Symptom Score by treatment group over a period of 55 years following randomization. The data is presented as a percentage of individuals experiencing the event, with the y-axis ranging from 0 to 25%. The treatment groups compared are "Combination" and "20F."*
finasteride-label.jpg - finasteride label
This is a description of a medication called Finasteride Tablets, USP. The product has a Global Trade Item Number (GTIN) of XOO00XX0000KX and comes in a bottle with 30 tablets. The National Drug Code (NDC) is listed as NaC 47335-715-3 5232313. The label indicates that it is available for full labeling and is for prescription use only. The pharmacist is instructed to dispense with patient information to each patient. Unfortunately, there is not enough information to determine the purpose or use of this medication.*
finasteride-structure - finasteride structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.